Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Saint-Gobain startet mit weniger Umsatz ins Jahr (DPA-AFX) +++ SAINT GOBAIN Aktie +3,79%

Zacks Nachrichten

Das amerikanische Research- Haus Zacks rankt Aktien und berichtet über wichtige Unternehmensmeldungen auf seiner Webseite unter zacks.com. Neben einer großen Anzahl an kostenlosen Artikeln werden auch zahlreiche bezahlbare Newsletter mit unterschiedlichen Strategien angeboten.
 
23.04.26 - 19:00
 Rogers Communications Q1 Earnings Beat Estimates, Revenues Rise Y/Y (Zacks)
 
RCI tops Q1 estimates as sales jump 15%, driven by strong Media growth and rising service revenues, while boosting free cash flow outlook....
23.04.26 - 19:00
 MITSY vs. HON: Which Stock Is the Better Value Option? (Zacks)
 
MITSY vs. HON: Which Stock Is the Better Value Option?...
23.04.26 - 19:00
 SNDK′s Rides on End-Market Diversification: Is the Model Paying Off? (Zacks)
 
Sandisk's diversified model gains traction as AI-driven datacenter demand, steady edge growth and consumer strength boost revenue resilience and visibility....
23.04.26 - 19:00
 QuantumScape Q1 Earnings Beat Estimates on Eagle Line Startup Progress (Zacks)
 
QuantumScape beats Q1 estimates as Eagle Line ramps, partner billings hit $11M, and liquidity stays strong....
23.04.26 - 19:00
 TIIAY vs. SCMWY: Which Stock Should Value Investors Buy Now? (Zacks)
 
TIIAY vs. SCMWY: Which Stock Is the Better Value Option?...
23.04.26 - 19:00
 XP vs. HLI: Which Stock Is the Better Value Option? (Zacks)
 
XP vs. HLI: Which Stock Is the Better Value Option?...
23.04.26 - 19:00
 BSBR vs. UOVEY: Which Stock Should Value Investors Buy Now? (Zacks)
 
BSBR vs. UOVEY: Which Stock Is the Better Value Option?...
23.04.26 - 19:00
 After Solid Q1, Should You Hold or Fold Goldman at Current Level? (Zacks)
 
GS' strong Q1 and IB rebound fuel growth, but premium valuation raises a key question: hold steady or wait for a better entry point?...
23.04.26 - 19:00
 NextEra Energy Beats Q1 Earnings Estimates, Revenues Rise Y/Y (Zacks)
 
NEE tops first-quarter earnings estimates as FPL and Energy Resources lift results, but revenues miss; renewables and storage origination add 4 GW....
23.04.26 - 19:00
 Xylem Gears Up to Report Q1 Earnings: What′s in the Offing? (Zacks)
 
XYL heads into Q1 results with modest revenue and EPS growth expected, backed by infrastructure demand and acquisitions despite cost pressures....
23.04.26 - 19:00
 HON′s Q1 Earnings Top Estimates, Aerospace Technologies Sales Up Y/Y (Zacks)
 
Honeywell tops Q1 profit estimates as aerospace and building units drive growth, but the revenue miss and margin pressure temper results....
23.04.26 - 19:00
 Cirrus Logic vs. Qualcomm: Which Mobile Chip Stock is the Better Buy? (Zacks)
 
CRUS stands out with strong stock gains, rising estimates and lower valuation, while QCOM faces supply constraints and cautious demand headwinds....
23.04.26 - 19:00
 Why Is KB Home (KBH) Up 6.6% Since Last Earnings Report? (Zacks)
 
KB Home (KBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues....
23.04.26 - 19:00
 Why Is AAR (AIR) Down 5.9% Since Last Earnings Report? (Zacks)
 
AAR (AIR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues....
23.04.26 - 19:00
 LVS Q1 Earnings Beat Estimates, Revenues Rise 25% YoY on MBS Growth (Zacks)
 
Las Vegas Sands tops Q1 estimates as net revenues jump 25% YoY, powered by Marina Bay Sands gains and improving Macao results....
23.04.26 - 19:00
 BDTX and the CNS-Active EGFR Trend: Why C797S Is the Prize (Zacks)
 
Black Diamond Therapeutics bets on brain-penetrant EGFR drug silevertinib, targeting C797S resistance and CNS metastases as key edge in crowded lung cancer market....
23.04.26 - 19:00
 Core Laboratories to Post Q1 Earnings: Key Metrics to Watch (Zacks)
 
CLB heads into Q1 earnings with lowered guidance, geopolitical disruptions and cost pressures raising concerns over a potential earnings miss....
23.04.26 - 19:00
 BDTX Stock: Neutral Zacks Rank, $4 Target, and What Must Go Right (Zacks)
 
Black Diamond Therapeutics hinges on silevertinib, with 2026 data on progression-free survival and durability set to determine whether its single-asset story can justify upside....
23.04.26 - 19:00
 Black Diamond′s Lead Drug Silevertinib: Key Data, Catalysts, and Risks (Zacks)
 
BDTX rides on silevertinib, with 2026 durability data set to test early NSCLC efficacy and CNS signals, making upcoming readouts a decisive swing factor....
23.04.26 - 19:00
 Graco Misses Q1 Earnings & Sales Estimates, Retains 2026 View (Zacks)
 
GGG misses Q1 estimates as organic sales decline and margins compress, but backlog growth and a steady 2026 outlook offer some stability....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Quod cito fit, cito perit - Was schnell entsteht, auch schnell vergeht. - Nomen Nescio
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!